Abstract:Pyridoxal 5′‐phosphate (PLP), the catalytically active form of vitamin B6, is produced by pyridox(am)ine 5′‐phosphate oxidase (PNPO) and pyridoxal kinase (PDXK). Both enzymes play roles in cancer progression. This study reveals that pyridoxilidenerhodanine 5′‐phosphate (PLP‐R), a PLP analogue, inhibits PNPO through a mixed competitive and allosteric mechanism. Additionally, PL‐R, the unphosphorylated precursor, is converted to PLP‐R by PDXK. This suggests a prototype prodrug‐drug system for developing new antineoplastic agents. Pyridoxal 5′‐phosphate (PLP), the catalytically active form of vitamin B6, acts as a cofactor in many metabolic processes. In humans, PLP is produced in the reactions catalysed by pyridox(am)ine 5′‐phosphate oxidase (PNPO) and pyridoxal kinase (PDXK). Both PNPO and PDXK are involved in cancer progression of many tumours. The silencing of PNPO and PDXK encoding genes determines a strong reduction in tumour size and neoplastic cell invasiveness in models of acute myeloid leukaemia (in the case of PDXK) and ovarian and breast cancer (in the case of PNPO). In the present work, we demonstrate that pyridoxilidenerhodanine 5′‐phosphate (PLP‐R), a PLP analogue that has been tested by other authors on malignant cell lines reporting a reduction in proliferation, inhibits PNPO in vitro following a mixed competitive and allosteric mechanism. We also show that the unphosphorylated precursor of this inhibitor (PL‐R), which has more favourable pharmacokinetic properties according to our predictions, is phosphorylated by PDXK and therefore transformed into PLP‐R. On this ground, we propose the prototype of a novel prodrug‐drug system as a useful starting point for the development of new, potential, antineoplastic agents.

[Recent advances in pyridoxal phosphate-dependent enzymes and their applications]

New reactions by pyridoxal phosphate-dependent enzymes

Conformational change of organic cofactor PLP is essential for catalysis in PLP-dependent enzymes

Species-Specific Features

Identification of the pyridoxal 5′‐phosphate allosteric site in human pyridox(am)ine 5′‐phosphate oxidase

Pyridoxal phosphate‐dependent reactions in natural products biosynthesis

The Z isomer of pyridoxilidenerhodanine 5′‐phosphate is an efficient inhibitor of human pyridoxine 5′‐phosphate oxidase, a crucial enzyme in vitamin B6 salvage pathway and a potential chemotherapeutic target

Inactive mutants of human pyridoxine 5′‐phosphate oxidase: a possible role for a noncatalytic pyridoxal 5′‐phosphate tight binding site

Molecular and Phylogenetic Analysis of Pyridoxal Phosphate- Dependent Acyltransferase of Exiguobacterium acetylicum

Elucidating the Interaction between Pyridoxine 5'-Phosphate Oxidase and Dopa Decarboxylase: Activation of B6-Dependent Enzyme

Molecular and phylogenetic analysis of pyridoxal phosphate-dependent acyltransferase of Exiguobacterium acetylicum

Two PYRIDOXAL PHOSPHATE HOMEOSTASIS PROTEINs are essential for management of the coenzyme in plants

Theoretical studies on pyridoxal 5'-phosphate-dependent transamination of alpha-amino acids.

Incorporation of pyridoxal-5'-phosphate into the apoenzyme: A structural study of D-amino acid transaminase from Haliscomenobacter hydrossis

A Novel Two-Dimensional Liquid Chromatography Combined with Ultraviolet Detection Method for Quantitative Determination of Pyridoxal 5′-Phosphate, 4-Pyridoxine Acid and Pyridoxal in Animal Plasma

Structural Insights into the Catalytic Mechanism of the Yeast Pyridoxal 5-Phosphate Synthase Snz1

Discovery and Characterization of Natural Product Luteolin As an Effective Inhibitor of Human Pyridoxal Kinase

Xanthine dehydrogenase: An old enzyme with new knowledge and prospects.

Nature-inspired radical pyridoxal-mediated C–C bond formation

A New Pyridoxal Derivative for Transamination of N-Terminus of Proteins

Discovery and Characterization of Pyridoxal 5’-Phosphate-Dependent Cycloleucine Synthases